Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Cleveland Clinic Launches Nationwide Clinical Trial for Magic Mushrooms

Mar 11 • 3 min read

At the forefront of medical innovation, the Cleveland Clinic is pioneering a study that revisits the potential of psychedelics, substances traditionally linked with recreational use, as a beacon of hope for mental health treatment. This ambitious research revolves around psilocybin, the primary psychoactive component in magic mushrooms, and its capacity to address various mental health…

The BlueSky Wellness and Lucy Scientific Deal is a No-Go

Mar 7 • 3 min read

In a recent turn of events, Vancouver’s BlueSky Wellness Inc. has decided to abandon its previously anticipated merger with Lucy Scientific Discovery (NASDAQ: LSDI), marking a significant shift in its corporate strategy. BlueSky, a prominent player in the e-commerce hemp sector, has expressed its intention to seek alternative partnerships to fuel its ongoing expansion and…

The Rising Curiosity in Psilocybin Gummies

Mar 5 • 12 min read

In recent years, the term “psilocybin gummies” and related search queries have seen a significant uptick on Google, signaling a marked increase in public interest towards psychedelic substances, specifically those that are more palatable and accessible. This article explores the reasons behind this surge, its implications, and what it tells us about the changing perceptions…

The State of Advertising Psychedelics Online

Mar 5 • 4 min read

In the vast expanse of the digital realm, where innovation meets regulation head-on, social media platforms like Meta (parent company of Facebook) find themselves in a relentless battle against the sale and advertisement of illegal substances. This complex issue involves the nuanced dance of algorithmic filtering, human moderation, and the ethical standards that these corporations…

Ketamine’s Short and Long-Term Effects on Depression

Mar 1 • 2 min read

A groundbreaking study by Northwestern Medicine has unveiled the intricate processes that enable ketamine to produce both immediate and enduring antidepressant effects. This breakthrough could lead to the development of novel, safer depression therapies. Distinct from conventional antidepressants, which often require weeks to manifest effects, ketamine offers rapid relief and maintains its benefits over time,…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354